Group 1 - The overall positioning of public funds has become clearer with the completion of the 2025 Q4 reports, showing a notable shift towards cyclical and small-cap growth stocks, while the allocation to Hong Kong stocks has decreased significantly from 19.26% to 16.23% [1] - The decline in the strategic position of Hong Kong stocks within active equity funds contrasts with the upward trend in the A-share market, raising concerns about the future performance of Hong Kong stocks [1] - The A-share market has shown a strong growth style, with significant thematic investment in sectors like commercial aerospace and artificial intelligence hardware, which are less represented in the Hong Kong market [2] Group 2 - Hong Kong stocks are facing dual pressures on liquidity, both from external factors and southbound capital, making them more sensitive to liquidity changes compared to A-shares [3] - Despite a record inflow of 1.4 trillion RMB from southbound capital in 2025, the pace has slowed significantly in Q4, with daily average inflows dropping to 10.9 million HKD in December [3] - The IPO market in Hong Kong has thrived, with 117 IPOs raising 285.9 billion HKD in 2025, marking a return to the top globally, but a potential wave of lock-up expirations could pose challenges [4][5] Group 3 - The upcoming lock-up expirations for major companies listed in the first half of 2025 could lead to significant selling pressure, with an estimated 120 billion HKD in potential unlocks by December [4] - Historical patterns indicate that lock-up expirations have coincided with declines in the Hong Kong market, although strong-performing companies may still attract new investments [5] - The market's current dynamics suggest that while there may be selling pressure from lock-up expirations, the presence of new buying forces could offset this impact [5]

Core Viewpoint - The company is actively focusing on modern frontier medical technologies, including smart healthcare and brain-computer interfaces, as indicated by its recent patent application in the field [1]. Group 1: Company Developments - The company has applied for a patent related to a DAC-GAN model construction method and its application in breast MR imaging [1]. - The primary function of the patented technology is to acquire and process breast MR image datasets, constructing a DAC-GAN model to predict breast MR images [1].

Group 1 - The core viewpoint of the article is that the company, Wuchan Zhongda, is actively exploring technology in the elderly care sector through collaboration with Strong Brain Technology, applying brain-computer interface technology to its elderly care business [1] Group 2 - Wuchan Zhongda's subsidiary, Wuchan Zhongda Jinshi Group Co., Ltd., is leading the initiative in technological advancements for elderly care [1] - The partnership with Strong Brain Technology signifies a strategic move towards integrating advanced technology into the company's services [1] - The focus on brain-computer interface technology indicates a commitment to enhancing the quality of elderly care through innovative solutions [1]

Core Viewpoint - The brain-computer interface (BCI) industry is identified as a long-term investment opportunity in the healthcare sector, with significant strategic importance for the company in the medical device field [1] Summary by Relevant Sections Industry Outlook - The implementation opinions jointly issued by seven departments, including the Ministry of Industry and Information Technology, aim to establish an advanced technology, industry, and standard system for the BCI industry by 2027, and to cultivate 2 to 3 globally influential leading enterprises by 2030 [1] Company Strategy - The company has been researching and exploring the BCI direction since 2023 and strategically invested in Hangzhou Qingshi Yongjun in 2025, successfully entering the invasive BCI treatment field for severe treatment-resistant depression [1] - The recent investment in Haoshi Tianhui further enhances the company's detection and treatment layout for depression and anxiety disorders within the BCI field [1] Future Plans - The company plans to continue its strategic layout in the BCI field by participating deeply through its investment platform, using its own funds for equity participation or acquisitions to accelerate the product industrialization and commercialization processes of invested enterprises [1] - Additionally, the company intends to establish a BCI industry fund, leveraging the strengths and resources of professional investment institutions to expedite its industrial chain layout in the BCI and neuroscience fields [1]

证券日报网讯1月23日，振江股份（603507）在互动平台回答投资者提问时表示，公司外骨骼机器人 2025年已在国内两三家景区落地，正推进与脑机接口企业的技术协同落地；具有防松螺纹技术的紧固件 已向中航工业送审并在航空航天领域产生少量收入。公司将持续披露新业务进展，以技术突破和业绩兑 现，推动市场重塑对公司"高端装备+硬科技"的价值认知。 ...

Core Insights - The National Intellectual Property Administration of China reported significant progress in intellectual property work by 2025, exceeding the goals set in the 14th Five-Year Plan [1] Group 1: Patent Statistics - By 2025, China is expected to authorize 972,000 invention patents and 1,461,000 utility model patents, with 96,000 cases of patent reexamination and invalidation concluded [1] - The effective number of invention patents in China (excluding Hong Kong, Macau, and Taiwan) is projected to reach 5.32 million by the end of 2025, with a high-value invention patent ownership rate of 16 per 10,000 people [3] Group 2: Trademark Developments - By 2025, China aims to have 4.206 million registered trademarks and resolve 384,000 trademark review cases, with an average trademark registration review period stable at 4 months and a pass rate exceeding 97% [6] - The effective number of registered trademarks in China is expected to reach 49.877 million by the end of 2025, with the value of Chinese brands in the global top 5,000 reaching $1.81 trillion, ranking second globally [6] Group 3: Geographical Indications - The direct annual output value of geographical indication products in China is close to 1 trillion yuan, marking five consecutive years of growth and contributing to regional economic development [7] - By 2025, China will have recognized 5,066 geographical indication products and approved 7,425 registrations for collective and certification trademarks [7] Group 4: Patent Utilization and Industrialization - The patent transfer and licensing record in China is expected to reach 697,000 by 2025, a year-on-year increase of 13.7%, with nearly 90,000 of these from universities and research institutions, reflecting a 16.6% increase [8] - The industrialization rate of enterprise invention patents is projected to reach 54% by 2025, indicating steady growth over the years [8] Group 5: Artificial Intelligence and Future Technologies - China has 2.292 million high-value invention patents, with the fastest growth in fields such as information technology management, computer technology, and medical technology, positioning itself as a leader in artificial intelligence patents globally [9] - Key core technology patents have been laid out in future industries such as quantum technology, biomanufacturing, brain-computer interfaces, and sixth-generation communications [9] Group 6: Public Service Network - During the 14th Five-Year Plan period, China has established a diverse and multi-dimensional public service network, with 519 national-level intellectual property public service institutions covering all provincial levels [10] - In collaboration with the World Intellectual Property Organization, China has built the largest and most comprehensive Technology and Innovation Support Center (TISC) network globally, with 202 centers [10] - Various public service institutions have served over 5 million innovation entities during the 14th Five-Year Plan period [12]

Core Viewpoint - The company plans to establish a specialized industry fund for brain-computer interfaces and brain science, with a total scale of 200 million yuan, to accelerate its strategic layout in this field [1] Group 1: Fund Details - The fund will be co-invested with professional investment institutions, with the company contributing 190 million yuan, accounting for 95% of the total committed capital [1] - The initial investment amount from the company is set at 50 million yuan, with the remaining contributions to be made based on project investment needs [1] Group 2: Investment Focus - The fund will target unlisted companies in the domestic and international brain-computer interface and brain science industry chain [1] - The aim is to enhance the company's industrial layout in brain-computer interfaces and neuroscience, promoting resource sharing and integration [1] Group 3: Strategic Goals - The fund seeks to achieve capital appreciation while serving the company's long-term strategic development goals [1] - The establishment of the fund is still pending approval from relevant authorities, and there are uncertainties regarding the smooth progress of investment projects [1]

Core Viewpoint - Botao Bio has received funding from the National Natural Science Foundation for a significant project focused on high-precision vascular interventional brain-machine interfaces, with direct funding amounting to 22 million yuan [1] Group 1 - The project titled "Research on Stent-free High-precision Vascular Interventional Brain-Machine Interfaces" is part of a major initiative under the National Natural Science Foundation [1] - Qingstone Yongjun is the only enterprise involved in this project, highlighting its unique position in the industry [1]

Market Overview - The Hong Kong stock market indices collectively rose on January 23, with the Hang Seng Index increasing by 0.45% to 26,749 points, the Hang Seng China Enterprises Index up by 0.51%, and the Hang Seng Tech Index rising by 0.62% [1][2]. Key Stock Movements - Major tech stocks saw gains, with Xiaomi Group and Kuaishou both rising nearly 3%, Alibaba up over 2%, and JD.com and Meituan also showing increases [2][4]. - The commercial aerospace sector experienced significant gains, with JunDa shares soaring over 51% following the launch of six platforms related to commercial aerospace in Beijing [6]. - Brain-computer interface stocks were active, with Lens Technology rising over 9% [7]. - Gold stocks continued to strengthen, with Zijin Mining International increasing by over 8% as gold prices reached new highs [9]. - Solar energy stocks surged, with Keyuan New Energy rising over 14% and several others following suit [10]. Sector Performance - The commercial aerospace sector led the market with notable gains, driven by the launch of new platforms aimed at enhancing the industry [6]. - The brain-computer interface sector showed strong activity, supported by advancements in flexible chip technology [7]. - Gold stocks benefited from rising gold prices, which reached a historical high of $4,940.78 per ounce [9]. - The solar energy sector was buoyed by positive remarks from Tesla's CEO regarding solar capacity expansion [10]. Individual Stock Highlights - JunDa shares rose by 51.40% to 39.00, while other aerospace-related stocks also saw significant increases [6]. - Lens Technology increased by 9.36% to 31.78, reflecting strong interest in brain-computer interface technologies [8]. - Zijin Mining International rose by 8.43% to 205.80, benefiting from the surge in gold prices [9]. - Keyuan New Energy saw a rise of 14.44% to 4.36, reflecting optimism in the solar energy market [11]. Future Outlook - The Hong Kong stock market is expected to see a recovery in profit growth by mid-2026, with a slowdown in competition among internet platforms and a reduction in the drag from non-essential consumer spending [26].

Core Viewpoint - The company,影石创新, is currently not involved in brain-computer interface technology but has developed a customized solution for a patient with ALS using their product, Link 2, in conjunction with third-party technology [1] Group 1: Company Technology and Products - The company provides a customized computer client called "Link Controller" that allows users to control the Link 2 camera through third-party brain-computer interfaces like Neuralink [1] - The Link 2 camera serves as a second pair of eyes for users, enabling them to see their surroundings through a camera feed displayed on a computer [1] - The company aims to leverage technology to help individuals experience life more fully and plans to continue focusing on the development, production, and sales of panoramic and action cameras [1]